Dermatological diseases in patients with chronic kidney disease

Journal of Nephropathology

Volumn 2, Issue 2, 2013, Pages 104-109

  Gagnon, Amy L ^a   Desai, Tejas ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Chronic kidney disease; Dermatological diseases; Malignancy; Renal transplantation

Indexed keywords

EID: 84925014318     PISSN: 22518363     EISSN: 22518819     Source Type: Journal    
DOI: 10.12860/JNP.2013.17     Document Type: Review

References (16)

1. Udayakumar P, Balasubramanian S, Ramalingam KS, Lakshmi C, Srinivas CR, Mathew AC. Cutaneous manifestations in patients with chronic renal failure on hemodialysis. Indian J Dermatol Venereol Leprol. 2006;72(2):119-25.
2. Kurban MS, Boueiz A, Kibbi AG. Cutaneous manifestations of chronic kidney disease. Clin Dermatol. 2008;26(3):255-64.
3. Alston H, Burns A. Half and half nails. Nephrol Dial Transplant. NDT Plus. 2011;4(5):361.
4. Markova A, Lester J, Wang J, Robinson-Bostom L. Diagnosis of common dermopathies in dialysis patients: a review and update. Semin Dial. 2012;25(4):408-18.
5. Szepietowski JC, Balaskas E, Taube KM, Taberly A, Dupuy P. Quality of life in patients with uraemic xerosis and pruritus. Acta Derm Venereol. 2011;91(3):313-7.
6. Avermaete A, Altmeyer P, Bacharach-Buhles M. Skin changes in dialysis patients: a review. Nephrol Dial Transplant. 2001;16(12):2293-6.
7. Castello M, Milani M. Efficacy of topical hydrating and emollient lotion containing 10% urea ISDIN(R) plus dexpanthenol (Ureadin Rx 10) in the treatment of skin xerosis and pruritus in hemodialyzed patients: an open prospective pilot trial. G Ital Dermatol Venereol. 2011;146(5):321-5.
8. Elmholdt TR, Pedersen M, Jorgensen B, Sondergaard K, Jensen JD, Ramsing M, et al, editor(s). Nephrogenic systemic fibrosis is found only among gadolinium-exposed patients with renal insufficiency: a case-control study from Denmark. Br J Dermatol. 2011;165(4):828-36.
9. Haemel AK, Sadowski EA, Shafer MM, Djamali A. Update on nephrogenic systemic fibrosis: are we making progress? Int J Dermatol. 2011;50(6):659-66.
10. Wong J, Phelps R, Levitt J. Treatment of acquired perforating dermatosis with cantharidin. Arch Dermatol. 2012;148(2):160-2.
11. Headley CM, Wall B. ESRD-associated cutaneous manifestations in a hemodialysis population. Nephrol Nurs J. 2002;29(6):525-7.
12. Hari Kumar KV, Prajapati J, Pavan G, Parthasarathy A, Jha R, Modi KD. Acquired perforating dermatoses in patients with diabetic kidney disease on hemodialysis. Hemodial Int. 2010;14(1):73-7.
13. Zavos G, Karidis NP, Tsourouflis G, Bokos J, Diles K, Sotirchos G, et al. Nonmelanoma skin cancer after renal transplantation: A single-center experience in 1736 transplantations. Int J Dermatol. 2011;50(12):1496-500.
14. Tessari G, Naldi L, Boschiero L, Minetti E, Sandrini S, Nacchia F, et al. Incidence of primary and second cancers in renal transplant recipients: a multicenter cohort study. Am J Transplant. 2012;13(1):214-21.
15. Nassar GM, Ayus JC. Infectious complications of the hemodialysis access. Kidney Int. 2001;60(1):1-13.
16. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol. 1998;9(5):869-76.